Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.

Balance Sheet for Kraig Biocraft Laboratories Inc (KBLB)
$ 0.0313   -0.00165 (-5.01%) Volume: 166.48k 3:56 PM EDT Sep 29, 2023
Statement: View:
Assets [+] in Thousands of Dollars
12/2022 12/2021 12/2020 12/2019 12/2018
Cash and Equivalents 3,863 2,355 817 125 14
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 7 - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories 7 - - - -
Prepaid Expenses 114 11 3 32 7
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 3,983 2,366 819 157 21
Land and Improvements - - - - -
Buildings and Improvement 83 83 85 85 8
Machinery, Furniture and Equipment 49 49 49 49 49
Construction in Progress - - - - -
Fixed Assets, Other 183 223 462 570 73
Fixed Assets, Total 315 355 596 704 130
Gross Fixed Assets 315 355 596 704 130
Accumulated Depreciation (168) (140) (142) (114) (83)
Net Fixed Assets 147 215 454 591 47
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - - - -
Total Non-Current Assets 587 656 458 594 51
Total Assets 4,571 3,022 1,277 751 71
Liabilities [+] in Thousands of Dollars
12/2022 12/2021 12/2020 12/2019 12/2018
Accounts Payable 962 1,000 5,468 4,772 4,209
Short Term Debt 134 608 235 171 -
Notes Payable 1,617 1,657 1,747 642 322
Accrued Expenses 5,359 4,897 - - -
Accrued Liabilities 5,359 4,897 - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - - -
Total Current Liabilities 8,072 8,163 7,451 5,584 4,531
Long Term Debt 168 95 145 185 N/A
Deferred Income Tax - - - - -
Other Non-Current Liabilities (5,385) (5,218) (5,218) (5,218) (5,218)
Minority Interest - - - - -
Capital Lease Obligations 21 60 255 369 -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 21 155 400 555 -
Total Liabilities 8,093 8,318 7,851 6,139 4,531
Preferred Shareholder's Equity 5,218 5,218 5,218 5,218 5,218
Common Shareholder's Equity (8,740) (10,514) (11,791) (10,606) (9,677)
Common Par 27,061 22,385 17,122 16,757 15,146
Additional Paid in Capital 10,835 9,894 5,834 2,413 2,043
Cumulative Translation Adjustments - - - - -
Retained Earnings (46,657) (42,815) (34,769) (29,798) (26,888)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization (3,354) (5,201) (6,428) (5,203) (4,459)
Total Equity (3,522) (5,296) (6,574) (5,388) (4,459)
Total Liabilities & Shareholder's Equity 4,571 3,022 1,277 751 71
Cash Flow (3,842) (8,046) (4,971) (2,910) (1,169)
Working Capital (4,089) (5,797) (6,631) (5,428) (4,510)
Free Cash Flow (1,892) (1,898) (1,255) (1,189) (246)
Invested Capital (3,522) (5,201) (6,428) (5,203) (4,459)
Shares Outstanding - Common Class Only 1,030,940 927,378 854,410 844,468 816,884
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 1,030,940 927,378 854,410 844,468 816,884
Total Common Shares Outstanding 1,030,940 927,378 854,410 844,468 816,884
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 974,307 877,612 848,651 835,587 816,874
Diluted Weighted Shares Outstanding 974,307 877,612 848,651 835,587 816,874

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT  Real-Time,  RTB  Real-Time BATS BZX Price/Quote; not sourced from all markets,  RTN  Real-Time NASDAQ Price/Quote; not sourced from all markets,  EOD  End Of Day,  PD  Previous Day.   H  Halted,  R  Restriction started today,  r   Restriction carried over from prior day .   Market Data powered by QuoteMedia. Financials by Morningstar.  Terms of Use.